{"url_path":"/sec/fbiop/8-k/2026-05-14/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **    **Financial Statements and Exhibits****.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-05-14","source_url":"https://www.sec.gov/Archives/edgar/data/1429260/0001104659-26-061208-index.html","accession_number":"0001104659-26-061208","cik":"0001429260","ticker":"FBIO","issuer_name":"Fortress Biotech, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1429260/0001104659-26-061208-index.html","primary_entity_key":"0001429260","primary_entity_name":"Fortress Biotech, Inc."},"word_count":111,"has_tables":true,"body_markdown":"**Item 9.01.**    **Financial Statements and Exhibits****.**\n\n​\n\n(d)    Exhibits.\n\nThe following exhibit is furnished herewith:\n\n99\n\n**Exhibit**\n**Number**\n\n**  ​ ​ ​**\n\n**Description**\n\n[99.1](fbio-20260514xex99.htm)\n\n \n\n[Press Release, dated May 14, 2026](fbio-20260514xex99.htm)\n\n104\n\n \n\nCover Page Interactive Data File (the cover page XBRL tags are imbedded in the Inline XBRL document)\n\n​\n\n**SIGNATURES**\n\n​\n\nPursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n​\n\n**Fortress Biotech, Inc.**\n\n​\n\n(Registrant)\n\n​\n\n​\n\nDate: May 14, 2026\n\n​\n\n​\n\n​\n\n \n\nBy:\n\n/s/ David Jin\n\n \n\n \n\nDavid Jin\n\n \n\n \n\nChief Financial Officer\n\n​\n\n​\n\n​\n\n​\n\n​"}